Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	COSMIC	MPOS	POSD
	SPEN(4.3%)	exon11,c.8770A>C,p.T2924P	0.043	0.06	203|7	21|0	0.03583	296|11	1	16261505	16261505	A	C	distinguished	SPEN	NM_015001.3	11	c.8770A>C	p.Thr2924Pro	missense_variant					21	0.0
-	ARID1A(31.4%)	exon20,c.5548del,p.D1850fs	0.314	0.07	92|44	17|0	0.27411	143|54	1	27105930	27105931	TG	T	distinguished	ARID1A	NM_006015.6	20	c.5548del	p.Asp1850fs	frameshift_variant					39	0.0
	WDTC1(63.5%)	exon9,c.868del,p.E290fs	0.635	0.066	73|121	18|0	0.59696	106|157	1	27621107	27621108	TG	T	distinguished	WDTC1	NM_001276252.2	9	c.868del	p.Glu290fs	frameshift_variant					33	0.0
-	CDKN2C(28.6%)	exon1,c.49del,p.D17fs	0.286	0.111	48|17	10|0	0.28750	57|23	1	51436083	51436084	AG	A	PASS	CDKN2C	NM_078626.3	1	c.49del	p.Asp17fs	frameshift_variant					35	0.0
	JAK1(1.3%)	exon9,c.1289del,p.P430fs	0.013	0.005688	2117|43	522|4	0.01353	4229|58	1	65325832	65325833	CG	C	suspected_bg	JAK1	NM_002227.4	9	c.1289del	p.Pro430fs	frameshift_variant					38	0.0
	CDC7(2.3%)	exon2,c.92del,p.N31fs	0.023	0.003624	2382|88	614|7	0.03138	5741|186	1	91967356	91967357	TA	T	multiallelic,slippage,suspected_bg	CDC7	NM_003503.4	2	c.92del	p.Asn31fs	frameshift_variant					40	0.0
	CDC7(2.0%)	exon2,c.92dup,p.N31fs	0.02	0.04	2382|69	614|28	0.03529	5741|210	1	91967356	91967357	TA	TAA	multiallelic,slippage,suspected_bg	CDC7	NM_003503.4	2	c.92dup	p.Asn31fs	frameshift_variant					43	0.0
	CDC7(0.5%)	exon2,c.84A>T,p.L28F	0.005057	0.003464	2652|16	684|1	0.03663	6154|234	1	91967357	91967357	A	T	background,low_allele_frac	CDC7	NM_003503.4	2	c.84A>T	p.Leu28Phe	missense_variant					23	0.0
1	NRAS(0.2%)	exon4,c.437C>T,p.A146V	0.001768	0.00123	5104|10	2161|2	0.00194	22160|43	1	115252203	115252203	G	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				COSV65746912	30	0.0
1	NRAS(0.1%)	exon4,c.436G>A,p.A146T	0.001429	0.000685	5110|10	2166|1	0.00076	22219|17	1	115252204	115252204	C	T	clustered_events,weak_evidence	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant				COSV65731978	55	0.0
1	NRAS(0.2%)	exon3,c.175G>A,p.A59T	0.002461	0.001167	2475|5	1203|0	0.00135	10327|14	1	115256536	115256536	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	3	c.175G>A	p.Ala59Thr	missense_variant	Likely_pathogenic		not_provided		43	0.0
1	NRAS(0.1%)	exon2,c.37G>A,p.G13S	0.001125	0.0006614	5292|5	2239|0	0.00117	23087|27	1	115258745	115258745	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.37G>A	p.Gly13Ser	missense_variant	Likely_pathogenic		Neoplasm_of_stomach		57	0.0
1	NRAS(0.1%)	exon2,c.34G>T,p.G12C	0.001102	0.001331	5283|4	2213|4	0.00226	22910|52	1	115258748	115258748	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.34G>T	p.Gly12Cys	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Non-small_cell_lung_carcinoma|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided		45	0.0
	RPTN(2.2%)	exon3,c.445C>T,p.P149S	0.022	0.027	2893|64	475|12	0.03907	13748|559	1	152129130	152129130	G	A	clustered_events,strand_bias,background	RPTN	NM_001122965.1	3	c.445C>T	p.Pro149Ser	missense_variant					21	0.0
	PIK3C2B(41.0%)	exon26,c.3594T>C,p.N1198=	0.41	0.167	25|20	8|0	0.43478	26|20	1	204403659	204403659	A	G	germline,Germline	PIK3C2B	NM_002646.4	26	c.3594T>C	p.Asn1198=	synonymous_variant				COSV65811498	39	0.0
	FCAMR(34.5%)	exon4,c.265C>T,p.L89F	0.345	0.049	100|53	25|0	0.31841	137|64	1	207139108	207139108	G	A	PASS	FCAMR	NM_001170631.2	4	c.265C>T	p.Leu89Phe	missense_variant					36	0.0
	MYCN(29.5%)	exon2,c.25A>G,p.M9V	0.295	0.029	122|56	51|0	0.30405	206|90	2	16082211	16082211	A	G	PASS	MYCN	NM_005378.6	2	c.25A>G	p.Met9Val	missense_variant					35	0.0
	MYCN(3.6%)	exon2,c.134del,p.P45fs	0.036	0.02	308|10	69|0	0.02863	509|15	2	16082313	16082314	AC	A	suspected_bg	MYCN	NM_005378.6	2	c.134del	p.Pro45fs	frameshift_variant					58	0.0
-	MSH2(2.3%)	exon2,c.212-6_212-4del	0.023	0.008244	360|27	100|0	0.03688	1123|43	2	47635523	47635526	CTTT	C	multiallelic,normal_artifact	MSH2	NM_000251.3	1	c.212-6_212-4del		splice_region_variant&intron_variant					37	0.0
-	MSH2(18.5%)	exon2,c.212-5_212-4del	0.185	0.016	360|183	100|2	0.21688	1123|311	2	47635523	47635526	CTTT	CT	multiallelic,normal_artifact	MSH2	NM_000251.3	1	c.212-5_212-4del		splice_region_variant&intron_variant	Likely_benign		not_specified		46	0.0
-	MSH2(32.9%)	exon2,c.212-4del	0.329	0.205	360|315	100|36	0.38229	1123|695	2	47635523	47635526	CTTT	CTT	multiallelic,normal_artifact,distinguished	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		40	0.0
-	MSH2(2.8%)	exon2,c.212-4dup	0.028	0.033	360|36	100|7	0.10232	1123|128	2	47635523	47635526	CTTT	CTTTT	multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	1	c.212-4dup		splice_region_variant&intron_variant	Benign		Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer		45	0.0
-	MSH6(7.1%)	exon5,c.3261del,p.F1088fs	0.071	0.065	2123|181	451|41	0.04631	6302|306	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided		37	0.0
-	MSH6(40.5%)	exon7,c.3557-6_3557-4del	0.405	0.063	42|27	21|1	0.41892	43|31	2	48032740	48032745	ATTTTT	ATT	multiallelic,normal_artifact	MSH6	NM_000179.3	6	c.3557-6_3557-4del		splice_region_variant&intron_variant					35	0.0
	RANBP2(46.9%)	exon18,c.2550A>G,p.S850=	0.469	0.167	26|22	6|0	0.40000	36|24	2	109374952	109374952	A	G	germline,Germline	RANBP2	NM_006267.5	18	c.2550A>G	p.Ser850=	synonymous_variant	Benign		Familial_acute_necrotizing_encephalopathy|not_specified		40	0.0
	RANBP2(3.9%)	exon20,c.5175A>G,p.E1725=	0.039	0.032	238|9	43|0	0.04010	383|16	2	109382170	109382170	A	G	contamination,background	RANBP2	NM_006267.5	20	c.5175A>G	p.Glu1725=	synonymous_variant	Likely_benign		Familial_acute_necrotizing_encephalopathy|not_provided		12	0.0
	LRP1B(2.2%)	exon80,c.12250C>T,p.R4084C	0.022	0.007407	830|16	215|0	0.01612	1221|20	2	141083421	141083421	G	A	contamination	LRP1B	NM_018557.3	80	c.12250C>T	p.Arg4084Cys	missense_variant				COSV67248198	38	0.0
	PDK1(36.4%)	exon8,c.899del,p.P300fs	0.364	0.018	165|111	70|0	0.34505	298|157	2	173435500	173435501	AC	A	PASS	PDK1	NM_002610.5	8	c.899del	p.Pro300fs	frameshift_variant					46	0.0
1	IDH1(0.2%)	exon4,c.394C>T,p.R132C	0.002442	0.001713	2450|6	801|0	0.00324	6456|21	2	209113113	209113113	G	A	clustered_events,orientation,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Enchondromatosis|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Prostate_adenocarcinoma|Glioblastoma|Myelodysplastic_syndrome|not_provided		16	0.0
	CUL3(29.5%)	exon11,c.1516C>T,p.R506W	0.295	0.012	424|184	144|0	0.29799	629|267	2	225365174	225365174	G	A	PASS	CUL3	NM_003590.5	11	c.1516C>T	p.Arg506Trp	missense_variant				COSV52369944	32	0.0
	UGT1A1(12.0%)	exon,c.-55_-54insAT	0.12	0.334	973|249	377|226	0.14372	6232|1046	2	234668879	234668883	CATAT	CATATAT	multiallelic,normal_artifact,distinguished,chemotherapy_site	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|_drug_response|_other	Pathogenic(7)|_Uncertain_significance(1)|_Benign(3)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided		49	0.0
	UGT1A1(0.9%)	exon,c.-55_-54insATAT	0.008526	0.024	973|18	377|15	0.00717	6232|45	2	234668879	234668883	CATAT	CATATATAT	multiallelic,normal_artifact,chemotherapy_site	UGT1A1	NM_000463.3		c.-55_-54insATAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|_drug_response	Pathogenic(2)|_Benign(1)	Irinotecan_response|not_provided		43	0.0
2	FANCD2(7.7%)	exon6,c.378-5del	0.077	0.073	1047|94	200|18	0.07087	1914|146	3	10076842	10076843	CT	C	normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	5	c.378-5del		splice_region_variant&intron_variant					52	0.0
	FANCD2(2.0%)	exon13,c.1014C>T,p.S338=	0.02	0.017	389|8	83|0	0.01515	520|8	3	10085192	10085192	C	T	contamination	FANCD2	NM_001018115.3	13	c.1014C>T	p.Ser338=	synonymous_variant	Likely_benign		Fanconi_anemia|not_provided		34	0.0
	TGFBR2(64.3%)	exon4,c.458del,p.K153fs	0.643	0.172	372|717	143|36	0.62831	759|1283	3	30691871	30691873	GAA	GA	multiallelic,normal_artifact,distinguished	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Benign(3)|_Likely_benign(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided		40	0.0
	ANO10(38.3%)	exon2,c.132del,p.D45fs	0.383	0.051	1489|984	553|38	0.38675	3915|2469	3	43647212	43647213	CT	C	multiallelic,normal_artifact,distinguished	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided		44	0.0
	ANO10(1.7%)	exon2,c.132dup,p.D45fs	0.017	0.018	1489|51	553|14	0.04208	3915|172	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,suspected_bg	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Abnormal_central_motor_function|Autosomal_recessive_spinocerebellar_ataxia_10|Autosomal_recessive_cerebellar_ataxia|not_provided		36	0.0
	TBC1D23(30.0%)	exon18,c.1947del,p.K649fs	0.3	0.021	1916|878	948|24	0.27151	5962|2222	3	100039735	100039736	CA	C	multiallelic,distinguished	TBC1D23	NM_001199198.3	18	c.1947del	p.Lys649fs	frameshift_variant					43	0.0
	TBC1D23(2.1%)	exon18,c.1947dup,p.H650fs	0.021	0.028	1916|81	948|40	0.04040	5962|251	3	100039735	100039736	CA	CAA	multiallelic,suspected_bg	TBC1D23	NM_001199198.3	18	c.1947dup	p.His650fs	frameshift_variant					41	0.0
	GSK3B(3.2%)	exon2,c.135G>A,p.G45=	0.032	0.045	212|6	35|0	0.02135	275|6	3	119721040	119721040	C	T	PASS	GSK3B	NM_002093.4	2	c.135G>A	p.Gly45=	synonymous_variant					50	0.0
	ATR(7.4%)	exon10,c.2320del,p.I774fs	0.074	0.052	3462|332	1280|97	0.06264	11881|794	3	142274739	142274740	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided		42	0.0
	ATR(1.6%)	exon10,c.2320dup,p.I774fs	0.016	0.015	3462|93	1280|35	0.03899	11881|482	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided		41	0.0
1	PIK3CA(34.0%)	exon2,c.263G>A,p.R88Q	0.34	0.0008775	3070|1587	1668|0	0.33594	10188|5154	3	178916876	178916876	G	A	PASS	PIK3CA	NM_006218.4	2	c.263G>A	p.Arg88Gln	missense_variant	Pathogenic		Abnormal_cerebral_morphology|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Gastric_adenocarcinoma|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Prostate_adenocarcinoma|Uterine_carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Cowden_syndrome|Glioblastoma|Malignant_neoplasm_of_body_of_uterus|PIK3CA_related_overgrowth_spectrum|not_provided		41	0.0
1	PIK3CA(0.1%)	exon10,c.1633G>A,p.E545K	0.00113	0.0007238	5027|5	2121|1	0.00045	13184|6	3	178936091	178936091	G	A	clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>A	p.Glu545Lys	missense_variant	Pathogenic/Likely_pathogenic		Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Segmental_undergrowth_associated_with_lymphatic_malformation|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Gastric_adenocarcinoma|Sarcoma|Neoplasm_of_ovary|Nasopharyngeal_neoplasm|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Gallbladder_carcinoma|Breast_adenocarcinoma|Prostate_adenocarcinoma|Gallbladder_cancer|Ovarian_serous_cystadenocarcinoma|Uterine_carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|CLOVES_syndrome|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|Eccrine_Angiomatous_Hamartoma|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided		53	0.0
1	PIK3CA(26.4%)	exon10,c.1634A>G,p.E545G	0.264	0.0007192	3685|1323	2120|0	0.26206	13018|4623	3	178936092	178936092	A	G	clustered_events	PIK3CA	NM_006218.4	10	c.1634A>G	p.Glu545Gly	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Melanoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Epidermal_nevus|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Gastric_adenocarcinoma|Nasopharyngeal_neoplasm|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Gallbladder_carcinoma|Prostate_adenocarcinoma|Ovarian_serous_cystadenocarcinoma|Uterine_carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus		42	0.0
1	PIK3CA(6.5%)	exon21,c.3140A>G,p.H1047R	0.065	0.0005419	5766|400	3504|1	0.05804	31680|1952	3	178952085	178952085	A	G	clustered_events	PIK3CA	NM_006218.4	21	c.3140A>G	p.His1047Arg	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|MACRODACTYLY,_SOMATIC|Segmental_undergrowth_associated_with_lymphatic_malformation|Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Neoplasm|Medulloblastoma|Adrenal_cortex_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Rosette-forming_glioneuronal_tumor|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Gastric_adenocarcinoma|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Breast_adenocarcinoma|Prostate_adenocarcinoma|Ovarian_serous_cystadenocarcinoma|Uterine_carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|CLOVES_syndrome|CLAPO_syndrome|Familial_cancer_of_breast|Glioblastoma|Lip_and_oral_cavity_carcinoma|Overgrowth_syndrome_and/or_cerebral_malformations_due_to_abnormalities_in_MTOR_pathway_genes|Malignant_neoplasm_of_body_of_uterus|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided		38	0.0
	RGS12(6.3%)	exon16,c.3534del,p.K1178fs	0.063	0.024	1591|133	173|5	0.06617	3147|223	4	3430398	3430399	GA	G	multiallelic,slippage,distinguished	RGS12	NM_198229.2	16	c.3534del	p.Lys1178fs	frameshift_variant					36	0.0
	EPHA5(23.9%)	exon12,c.2077C>T,p.R693C	0.239	0.007339	488|151	204|0	0.22323	682|196	4	66230894	66230894	G	A	PASS	EPHA5	NM_004439.8	12	c.2077C>T	p.Arg693Cys	missense_variant				COSV56649751	41	0.0
	EPHA5(34.5%)	exon2,c.242del,p.N81fs	0.345	0.022	175|84	67|0	0.31285	246|112	4	66509084	66509085	AT	A	PASS	EPHA5	NM_004439.8	2	c.242del	p.Asn81fs	frameshift_variant					38	0.0
	SEC31A(59.8%)	exon11,c.1384del,p.I462fs	0.598	0.015	839|1212	627|10	0.58121	1957|2716	4	83785564	83785565	AT	A	distinguished	SEC31A	NM_001077207.4	11	c.1384del	p.Ile462fs	frameshift_variant					45	0.0
	TET2(0.5%)	exon11,c.4716G>A,p.R1572=	0.005092	0.003854	1489|8	368|0	0.00369	2966|11	4	106196383	106196383	G	A	low_allele_frac	TET2	NM_001127208.3	11	c.4716G>A	p.Arg1572=	synonymous_variant				COSV105020536	64	0.0
	SDHA(7.5%)	exon9,c.1145G>A,p.G382D	0.075	0.125	60|4	11|0	0.05714	66|4	5	235339	235339	G	A	PASS	SDHA	NM_004168.4	9	c.1145G>A	p.Gly382Asp	missense_variant	Uncertain_significance		Paragangliomas_5|Mitochondrial_complex_II_deficiency,_nuclear_type_1		43	0.0
	IL7R(27.1%)	exon3,c.361del,p.I121*	0.271	0.026	138|45	58|0	0.27273	168|63	5	35867540	35867541	CA	C	distinguished	IL7R	NM_002185.5	3	c.361del	p.Ile121*	frameshift_variant&stop_gained					38	0.0
	MSH3(61.1%)	exon7,c.1148del,p.K383fs	0.611	0.022	1125|1805	1054|36	0.58464	3435|4835	5	79970914	79970915	CA	C	multiallelic,distinguished	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided		37	0.0
	MSH3(0.8%)	exon7,c.1148dup,p.N385fs	0.008364	0.013	1125|32	1054|23	0.02359	3435|83	5	79970914	79970915	CA	CAA	multiallelic,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided		36	0.0
-	APC(7.0%)	exon5,c.423-5_423-4del	0.07	0.012	289|55	83|0	0.09582	736|78	5	112111309	112111311	TAA	T	multiallelic,normal_artifact	APC	NM_000038.6	4	c.423-5_423-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		40	0.0
-	APC(38.0%)	exon5,c.423-4del	0.38	0.137	289|237	83|18	0.38870	736|468	5	112111309	112111311	TAA	TA	multiallelic,normal_artifact,distinguished	APC	NM_000038.6	4	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Colorectal_cancer|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|not_provided		40	0.0
-	APC(5.8%)	exon5,c.423-4dup	0.058	0.09	289|44	83|12	0.11432	736|95	5	112111309	112111311	TAA	TAAA	multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	4	c.423-4dup		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified		45	0.0
	RAD50(5.2%)	exon13,c.2165del,p.K722fs	0.052	0.033	1834|118	353|16	0.04773	4449|223	5	131931451	131931452	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome		45	0.0
	RAD50(1.5%)	exon13,c.2165dup,p.E723fs	0.015	0.008559	1834|50	353|3	0.02775	4449|127	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided		42	0.0
	RAD50(27.9%)	exon24,c.3659C>T,p.T1220M	0.279	0.018	306|121	82|0	0.27069	423|157	5	131976404	131976404	C	T	PASS	RAD50	NM_005732.4	24	c.3659C>T	p.Thr1220Met	missense_variant					34	0.0
	HAVCR1(2.0%)	exon3,c.599_601del,p.T200del	0.02	0.005983	1441|24	228|0	0.01485	5905|89	5	156479443	156479446	CTTG	C	contamination,haplotype,slippage,suspected_bg	HAVCR1	NM_012206.3	3	c.599_601del	p.Thr200del	disruptive_inframe_deletion					59	0.0
	FLT4(5.2%)	exon2,c.89del,p.P30fs	0.052	0.075	193|11	35|2	0.04965	268|14	5	180058747	180058748	CG	C	normal_artifact,weak_evidence,distinguished	FLT4	NM_182925.5	2	c.89del	p.Pro30fs	frameshift_variant	Pathogenic		Congenital_heart_defects,_multiple_types,_7|not_provided		27	0.0
	ABCF1(7.2%)	exon4,c.227del,p.K76fs	0.072	0.119	144|15	7|0	0.10196	229|26	6	30545853	30545854	CA	C	multiallelic,slippage,suspected_bg	ABCF1	NM_001025091.2	4	c.227del	p.Lys76fs	frameshift_variant					58	0.0
	ABCF1(9.0%)	exon4,c.227dup,p.R77fs	0.09	0.118	144|17	7|0	0.10895	229|28	6	30545853	30545854	CA	CAA	multiallelic,slippage,background	ABCF1	NM_001025091.2	4	c.227dup	p.Arg77fs	frameshift_variant					49	0.0
	HLA-DQA1(4.8%)	exon2,c.122_126delinsCTTAT,p.F41S	0.048	0.09	134|7	22|1	0.03911	172|7	6	32609126	32609130	TTTAC	CTTAT	normal_artifact	HLA-DQA1	NM_002122.5	2	c.122_126delinsCTTAT	p.Phe41Ser	missense_variant					50	0.0
	GRIK2(30.8%)	exon16,c.2546del,p.N849fs	0.308	0.022	552|406	404|9	0.39474	1173|765	6	102503431	102503432	CA	C	multiallelic,distinguished	GRIK2	NM_021956.5	16	c.2546del	p.Asn849fs	frameshift_variant					43	0.0
	GRIK2(23.5%)	exon16,c.2546dup,p.N849fs	0.235	0.017	552|312	404|9	0.32314	1173|560	6	102503431	102503432	CA	CAA	multiallelic,distinguished	GRIK2	NM_021956.5	16	c.2546dup	p.Asn849fs	frameshift_variant					42	0.0
	GRIK2(3.0%)	exon16,c.2545_2546dup,p.N849fs	0.03	0.003445	552|44	404|0	0.07346	1173|93	6	102503431	102503432	CA	CAAA	multiallelic	GRIK2	NM_021956.5	16	c.2545_2546dup	p.Asn849fs	frameshift_variant					40	0.0
	CARD11(20.0%)	exon10,c.1348C>T,p.P450S	0.2	0.042	167|43	37|0	0.19922	205|51	7	2974257	2974257	G	A	distinguished	CARD11	NM_032415.7	10	c.1348C>T	p.Pro450Ser	missense_variant				COSV62757330	45	0.0
	PMS2(26.4%)	exon11,c.1239del,p.D414fs	0.264	0.054	97|33	18|0	0.26238	149|53	7	6027156	6027157	CT	C	map_qual,distinguished	PMS2	NM_000535.7	11	c.1239del	p.Asp414fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome		33	0.0
2	PMS2(11.3%)	exon7,c.706-10_706-4del	0.113	0.016	44|131	16|0	0.19926	868|216	7	6037057	6037064	GAAAAAAA	G	multiallelic	PMS2	NM_000535.7	6	c.706-10_706-4del		splice_region_variant&intron_variant					51	0.0
2	PMS2(44.5%)	exon7,c.706-9_706-4del	0.445	0.017	44|448	16|0	0.55894	868|1100	7	6037057	6037064	GAAAAAAA	GA	multiallelic	PMS2	NM_000535.7	6	c.706-9_706-4del		splice_region_variant&intron_variant					48	0.0
2	PMS2(7.9%)	exon7,c.706-8_706-4del	0.079	0.018	44|85	16|0	0.19630	868|212	7	6037057	6037064	GAAAAAAA	GAA	multiallelic	PMS2	NM_000535.7	6	c.706-8_706-4del		splice_region_variant&intron_variant					50	0.0
2	PMS2(4.9%)	exon7,c.706-6_706-4del	0.049	0.119	44|41	16|6	0.11247	868|110	7	6037057	6037064	GAAAAAAA	GAAAA	multiallelic	PMS2	NM_000535.7	6	c.706-6_706-4del		splice_region_variant&intron_variant	Benign		Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|not_provided		50	0.0
2	PMS2(10.9%)	exon7,c.706-5_706-4del	0.109	0.24	44|89	16|12	0.21661	868|240	7	6037057	6037064	GAAAAAAA	GAAAAA	multiallelic	PMS2	NM_000535.7	6	c.706-5_706-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_4|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified		49	0.0
2	PMS2(15.5%)	exon7,c.706-4del	0.155	0.311	44|110	16|18	0.26190	868|308	7	6037057	6037064	GAAAAAAA	GAAAAAA	multiallelic,Germline	PMS2	NM_000535.7	6	c.706-4del		splice_region_variant&intron_variant	Benign		Neoplasm_of_ovary|Lynch_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_4|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|Breast_and/or_ovarian_cancer|not_provided		43	0.0
1	EGFR(0.2%)	exon18,c.2153T>A,p.L718Q	0.001973	0.003619	1448|4	393|3	0.00245	3663|9	7	55241705	55241705	T	A	base_qual,clustered_events,weak_evidence	EGFR	NM_005228.5	18	c.2153T>A	p.Leu718Gln	missense_variant				COSV51834362	39	0.0
	MAGI2(29.2%)	exon2,c.406C>T,p.R136C	0.292	0.008897	385|155	145|0	0.28625	571|229	7	78636418	78636418	G	A	PASS	MAGI2	NM_012301.4	2	c.406C>T	p.Arg136Cys	missense_variant				COSV62637981	28	0.0
1	MET(0.1%)	exon14,c.3028+1G>A	0.001011	0.001092	6114|5	5086|3	0.00125	52014|65	7	116412044	116412044	G	A	clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided		18	0.0
-	KMT2C(1.6%)	exon38,c.8390dup,p.E2798fs	0.016	0.015	4194|114	2143|53	0.03598	20714|773	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided		34	0.0
	GOT1L1(24.5%)	exon9,c.1243del,p.T415fs	0.245	0.017	2375|815	606|14	0.25094	7370|2469	8	37791833	37791834	GT	G	multiallelic,distinguished	GOT1L1	NM_152413.3	9	c.1243del	p.Thr415fs	frameshift_variant					33	0.0
	FGFR1(0.8%)	exon4,c.381T>G,p.D127E	0.008409	0.003982	2159|19	379|0	0.00874	4766|42	8	38285931	38285931	A	C	background	FGFR1	NM_023110.3	4	c.381T>G	p.Asp127Glu	missense_variant	Uncertain_significance		Pfeiffer_syndrome|Hypogonadotropic_hypogonadism_2_with_or_without_anosmia		36	0.0
	KCNB2(27.4%)	exon2,c.435del,p.E146fs	0.274	0.007086	742|290	180|0	0.24442	1354|438	8	73480396	73480397	CA	C	distinguished	KCNB2	NM_004770.3	2	c.435del	p.Glu146fs	frameshift_variant					33	0.0
	UBR5(45.2%)	exon45,c.6360del,p.E2121fs	0.452	0.003608	3322|2843	2003|14	0.44682	14890|12027	8	103289348	103289350	CTT	CT	clustered_events,multiallelic,distinguished	UBR5	NM_015902.6	45	c.6360del	p.Glu2121fs	frameshift_variant					38	0.0
	MLLT3(4.8%)	exon5,c.531_533del,p.S178del	0.048	0.013	199|29	36|0	0.08359	3804|347	9	20414310	20414313	ACTG	A	clustered_events,multiallelic,slippage,suspected_bg	MLLT3	NM_004529.4	5	c.531_533del	p.Ser178del	disruptive_inframe_deletion					26	0.0
	MLLT3(2.2%)	exon5,c.531_533dup,p.S178dup	0.022	0.012	199|12	36|0	0.00989	3804|38	9	20414310	20414313	ACTG	ACTGCTG	clustered_events,multiallelic,slippage	MLLT3	NM_004529.4	5	c.531_533dup	p.Ser178dup	disruptive_inframe_insertion					53	0.0
	NTRK2(24.6%)	exon6,c.508_511del,p.D170fs	0.246	0.013	576|181	95|0	0.25072	777|260	9	87325628	87325632	CCAGA	C	PASS	NTRK2	NM_006180.6	6	c.508_511del	p.Asp170fs	frameshift_variant					35	0.0
	SYK(4.0%)	exon8,c.966G>A,p.P322=	0.04	0.072	175|6	19|0	0.03571	216|8	9	93636536	93636536	G	A	distinguished	SYK	NM_003177.7	8	c.966G>A	p.Pro322=	synonymous_variant				COSV65327852	35	0.0
2	FANCC(19.6%)	exon5,c.346-3del	0.196	0.005306	816|203	263|2	0.19132	1602|379	9	97934431	97934432	TA	T	PASS	FANCC	NM_000136.3	4	c.346-3del		splice_region_variant&intron_variant	Benign		Fanconi_anemia		47	0.0
	PTCH1(17.7%)	exon23,c.4171C>T,p.R1391W	0.177	0.071	93|19	16|0	0.17143	116|24	9	98209367	98209367	G	A	PASS	PTCH1	NM_000264.5	23	c.4171C>T	p.Arg1391Trp	missense_variant	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(1)|_Likely_benign(3)	Gorlin_syndrome|Hereditary_cancer-predisposing_syndrome|Inborn_genetic_diseases|not_provided		36	0.0
-	PTCH1(26.6%)	exon23,c.3921del,p.R1308fs	0.266	0.029	232|92	41|0	0.25641	406|140	9	98209616	98209617	TG	T	distinguished	PTCH1	NM_000264.5	23	c.3921del	p.Arg1308fs	frameshift_variant	Pathogenic		Gorlin_syndrome		33	0.0
-	PTCH1(28.8%)	exon22,c.3606del,p.S1203fs	0.288	0.025	247|104	55|0	0.27872	383|148	9	98211548	98211549	TG	T	distinguished	PTCH1	NM_000264.5	22	c.3606del	p.Ser1203fs	frameshift_variant					46	0.0
	PTCH1(21.1%)	exon21,c.3490G>A,p.V1164I	0.211	0.02	883|233	141|1	0.20538	1389|359	9	98212182	98212182	C	T	PASS	PTCH1	NM_000264.5	21	c.3490G>A	p.Val1164Ile	missense_variant	Uncertain_significance		Cataract|Disproportionate_tall_stature|Abnormality_of_cardiovascular_system_morphology|Gorlin_syndrome|Hereditary_cancer-predisposing_syndrome		37	0.0
	PTCH1(2.4%)	exon16,c.2678G>A,p.R893H	0.024	0.047	237|5	24|0	0.02439	320|8	9	98224163	98224163	C	T	contamination	PTCH1	NM_000264.5	16	c.2678G>A	p.Arg893His	missense_variant	Benign/Likely_benign		Gorlin_syndrome|Holoprosencephaly_7|Hereditary_cancer-predisposing_syndrome|not_provided		29	0.0
	PTCH1(14.7%)	exon12,c.1716G>A,p.A572=	0.147	0.03	234|41	48|0	0.15230	295|53	9	98238328	98238328	C	T	PASS	PTCH1	NM_000264.5	12	c.1716G>A	p.Ala572=	synonymous_variant	Benign/Likely_benign		Gorlin_syndrome|Hereditary_cancer-predisposing_syndrome		37	0.0
	ABL1(3.1%)	exon11,c.1826_1828del,p.K609del	0.031	0.034	414|11	33|0	0.02097	887|19	9	133759489	133759492	CAAG	C	contamination,slippage,suspected_bg	ABL1	NM_005157.6	11	c.1826_1828del	p.Lys609del	disruptive_inframe_deletion					28	0.0
	BRD3(18.5%)	exon2,c.166G>A,p.A56T	0.185	0.167	89|22	6|0	0.24818	103|34	9	136918434	136918434	C	T	PASS	BRD3	NM_007371.4	2	c.166G>A	p.Ala56Thr	missense_variant					61	0.0
-	PTEN(5.9%)	exon8,c.802-6_802-3del	0.059	0.05	50|24	6|0	0.09955	398|44	10	89720633	89720637	CTTTT	C	multiallelic,normal_artifact	PTEN	NM_000314.8	7	c.802-6_802-3del		splice_region_variant&intron_variant					27	0.0
-	PTEN(23.7%)	exon8,c.802-5_802-3del	0.237	0.163	50|81	6|3	0.34432	398|209	10	89720633	89720637	CTTTT	CT	multiallelic,normal_artifact	PTEN	NM_000314.8	7	c.802-5_802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome		29	0.0
-	PTEN(37.7%)	exon8,c.802-4_802-3del	0.377	0.148	50|107	6|2	0.47563	398|361	10	89720633	89720637	CTTTT	CTT	multiallelic,normal_artifact	PTEN	NM_000314.8	7	c.802-4_802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		36	0.0
-	PTEN(15.8%)	exon8,c.802-3del	0.158	0.18	50|55	6|2	0.36218	398|226	10	89720633	89720637	CTTTT	CTTT	multiallelic,normal_artifact,Germline	PTEN	NM_000314.8	7	c.802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided		29	0.0
	IFITM3(15.7%)	exon1,c.165C>T,p.P55=	0.157	0.167	82|17	5|0	0.21488	95|26	11	320649	320649	G	A	Germline	IFITM3	NM_021034.3	1	c.165C>T	p.Pro55=	synonymous_variant				COSV67706701	61	0.0
	HRAS(2.0%)	exon2,c.81T>C,p.H27=	0.02	0.017	693|13	86|0	0.01850	1326|25	11	534242	534242	A	G	contamination,haplotype,background	HRAS	NM_005343.4	2	c.81T>C	p.His27=	synonymous_variant	Benign		Squamous_cell_lung_carcinoma|Costello_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|not_specified|not_provided		43	0.0
	EMSY(1.9%)	exon20,c.3730G>T,p.G1244C	0.019	0.04	318|8	31|0	0.02025	387|8	11	76257297	76257297	G	T	PASS	EMSY	NM_020193.5	20	c.3730G>T	p.Gly1244Cys	missense_variant					51	0.0
	CASP5(32.8%)	exon2,c.27_28del,p.R10fs	0.328	0.014	1512|943	790|17	0.33907	4725|2424	11	104879686	104879688	CTT	C	multiallelic	CASP5	NM_004347.5	2	c.27_28del	p.Arg10fs	frameshift_variant					38	0.0
	CASP5(12.2%)	exon2,c.28del,p.R10fs	0.122	0.145	1512|392	790|159	0.15216	4725|848	11	104879686	104879688	CTT	CT	multiallelic,suspected_bg	CASP5	NM_004347.5	2	c.28del	p.Arg10fs	frameshift_variant					37	0.0
-	ATM(6.6%)	exon6,c.497-7_497-4del	0.066	0.056	76|21	10|0	0.13014	254|38	11	108114661	108114665	ATTTT	A	multiallelic	ATM	NM_000051.4	5	c.497-7_497-4del		splice_region_variant&intron_variant					33	0.0
-	ATM(43.2%)	exon6,c.497-6_497-4del	0.432	0.056	76|132	10|0	0.47521	254|230	11	108114661	108114665	ATTTT	AT	multiallelic	ATM	NM_000051.4	5	c.497-6_497-4del		splice_region_variant&intron_variant					33	0.0
-	ATM(5.6%)	exon6,c.497-5_497-4del	0.056	0.056	76|21	10|0	0.16447	254|50	11	108114661	108114665	ATTTT	ATT	multiallelic	ATM	NM_000051.4	5	c.497-5_497-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		52	0.0
-	ATM(16.5%)	exon6,c.497-4del	0.165	0.253	76|45	10|4	0.29640	254|107	11	108114661	108114665	ATTTT	ATTT	multiallelic,suspected_bg	ATM	NM_000051.4	5	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|not_provided		36	0.0
-	ATM(9.5%)	exon10,c.1236-8_1236-3del	0.095	0.038	23|48	9|0	0.34906	138|74	11	108121410	108121416	CTTTTTT	C	multiallelic	ATM	NM_000051.4	9	c.1236-8_1236-3del		splice_region_variant&intron_variant					46	0.0
-	ATM(51.0%)	exon10,c.1236-7_1236-3del	0.51	0.04	23|217	9|0	0.73913	138|391	11	108121410	108121416	CTTTTTT	CT	multiallelic	ATM	NM_000051.4	9	c.1236-7_1236-3del		splice_region_variant&intron_variant					44	0.0
-	ATM(25.9%)	exon10,c.1236-6_1236-3del	0.259	0.04	23|101	9|0	0.61667	138|222	11	108121410	108121416	CTTTTTT	CTT	multiallelic	ATM	NM_000051.4	9	c.1236-6_1236-3del		splice_region_variant&intron_variant					46	0.0
-	ATM(3.4%)	exon10,c.1236-5_1236-3del	0.034	0.05	23|11	9|0	0.17857	138|30	11	108121410	108121416	CTTTTTT	CTTT	multiallelic	ATM	NM_000051.4	9	c.1236-5_1236-3del		splice_region_variant&intron_variant					42	0.0
-	ATM(3.9%)	exon10,c.1236-3del	0.039	0.399	23|11	9|5	0.16867	138|28	11	108121410	108121416	CTTTTTT	CTTTTT	multiallelic,suspected_bg	ATM	NM_000051.4	9	c.1236-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided		46	0.0
	ATM(31.6%)	exon60,c.8678C>T,p.A2893V	0.316	0.01	507|242	161|0	0.30797	755|336	11	108224499	108224499	C	T	PASS	ATM	NM_000051.4	60	c.8678C>T	p.Ala2893Val	missense_variant				COSV53746986	44	0.0
	CD3G(5.4%)	exon3,c.213del,p.K71fs	0.054	0.03	1220|87	236|8	0.05068	2304|123	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Severe_combined_immunodeficiency_disease|Combined_immunodeficiency_due_to_CD3gamma_deficiency		43	0.0
	CD3G(2.3%)	exon3,c.213dup,p.W72fs	0.023	0.005522	1220|35	236|1	0.03153	2304|75	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,background	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic/Likely_pathogenic		Severe_combined_immunodeficiency_disease|Combined_immunodeficiency_due_to_CD3gamma_deficiency		41	0.0
	KMT2A(31.1%)	exon3,c.1512C>T,p.S504=	0.311	0.03	196|87	40|0	0.31161	243|110	11	118343386	118343386	C	T	PASS	KMT2A	NM_001197104.2	3	c.1512C>T	p.Ser504=	synonymous_variant					47	0.0
	KMT2A(33.0%)	exon3,c.2318del,p.P773fs	0.33	0.013	3052|1553	1030|19	0.30093	9794|4216	11	118344185	118344186	AC	A	distinguished	KMT2A	NM_001197104.2	3	c.2318del	p.Pro773fs	frameshift_variant	Pathogenic		Wiedemann-Steiner_syndrome|Inborn_genetic_diseases		39	0.0
	KDM5A(2.5%)	exon23,c.3597del,p.G1200fs	0.025	0.021	890|27	187|3	0.02168	1489|33	12	416952	416953	CT	C	multiallelic,slippage,suspected_bg	KDM5A	NM_001042603.3	23	c.3597del	p.Gly1200fs	frameshift_variant					35	0.0
	KDM5A(3.7%)	exon23,c.3597dup,p.G1200fs	0.037	0.007997	890|34	187|1	0.03249	1489|50	12	416952	416953	CT	CTT	multiallelic,slippage,suspected_bg	KDM5A	NM_001042603.3	23	c.3597dup	p.Gly1200fs	frameshift_variant					38	0.0
	CHD4(28.9%)	exon21,c.3114C>T,p.G1038=	0.289	0.003036	1211|493	458|0	0.27422	2779|1050	12	6700968	6700968	G	A	PASS	CHD4	NM_001273.5	21	c.3114C>T	p.Gly1038=	synonymous_variant					35	0.0
1	KRAS(0.1%)	exon4,c.437C>T,p.A146V	0.001106	0.0008902	5009|4	3591|2	0.00045	30808|14	12	25378561	25378561	G	A	orientation,weak_evidence	KRAS	NM_033360.4	4	c.437C>T	p.Ala146Val	missense_variant	Pathogenic		OCULOECTODERMAL_SYNDROME,_SOMATIC|Non-small_cell_lung_carcinoma|Thyroid_tumor|Neoplasm_of_the_large_intestine|Encephalocraniocutaneous_lipomatosis		2	0.0
1	KRAS(3.9%)	exon4,c.436G>A,p.A146T	0.039	0.002067	4853|193	3617|5	0.03557	31068|1146	12	25378562	25378562	C	T	PASS	KRAS	NM_033360.4	4	c.436G>A	p.Ala146Thr	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Uncertain_significance(2)	OCULOECTODERMAL_SYNDROME,_SOMATIC|Classic_Hodgkin_lymphoma|Neoplasm_of_the_large_intestine|Encephalocraniocutaneous_lipomatosis|RASopathy|not_provided		31	0.0
1	KRAS(2.6%)	exon2,c.35G>A,p.G12D	0.026	0.000525	4588|118	2827|0	0.01241	22444|282	12	25398284	25398284	C	T	clustered_events	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Vascular_Tumors_Including_Pyogenic_Granuloma|Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Neoplasm_of_stomach|Nevus_sebaceous|Epidermal_nevus|Linear_nevus_sebaceous_syndrome|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Thyroid_tumor|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Carcinoma_of_pancreas|Encephalocraniocutaneous_lipomatosis|Autoimmune_lymphoproliferative_syndrome_type_4|Capillary_malformation-arteriovenous_malformation_1|RASopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|not_provided		40	0.0
	KMT2D(6.6%)	exon47,c.14466C>T,p.S4822=	0.066	0.125	79|4	7|0	0.05435	87|5	12	49421841	49421841	G	A	PASS	KMT2D	NM_003482.4	47	c.14466C>T	p.Ser4822=	synonymous_variant					18	0.0
-	KMT2D(44.0%)	exon32,c.7061del,p.P2354fs	0.44	0.106	41|36	9|1	0.50331	75|76	12	49434491	49434492	AG	A	PASS	KMT2D	NM_003482.4	32	c.7061del	p.Pro2354fs	frameshift_variant					55	0.0
	KMT2D(2.7%)	exon12,c.2987T>G,p.V996G	0.027	0.04	202|6	31|1	0.06438	436|30	12	49444384	49444384	A	C	orientation,suspected_bg	KMT2D	NM_003482.4	12	c.2987T>G	p.Val996Gly	missense_variant					41	0.0
	OR6C76(39.4%)	exon1,c.931_933del,p.K311del	0.394	0.011	506|1195	498|8	0.59084	3002|4335	12	55820958	55820962	CAAAA	CA	multiallelic	OR6C76	NM_001005183.1	1	c.931_933del	p.Lys311del	conservative_inframe_deletion					42	0.0
	OR6C76(29.8%)	exon1,c.932_933del,p.K311fs	0.298	0.015	506|896	498|16	0.53240	3002|3418	12	55820958	55820962	CAAAA	CAA	multiallelic	OR6C76	NM_001005183.1	1	c.932_933del	p.Lys311fs	frameshift_variant					41	0.0
	OR6C76(8.1%)	exon1,c.933del,p.K311fs	0.081	0.146	506|269	498|123	0.24554	3002|977	12	55820958	55820962	CAAAA	CAAA	multiallelic,suspected_bg	OR6C76	NM_001005183.1	1	c.933del	p.Lys311fs	frameshift_variant					42	0.0
	OR6C76(3.5%)	exon1,c.933dup,p.H312fs	0.035	0.133	506|104	498|115	0.17003	3002|615	12	55820958	55820962	CAAAA	CAAAAA	multiallelic,suspected_bg	OR6C76	NM_001005183.1	1	c.933dup	p.His312fs	frameshift_variant					37	0.0
	ERBB3(2.5%)	exon2,c.132C>T,p.N44=	0.025	0.018	265|6	58|0	0.01339	442|6	12	56477584	56477584	C	T	contamination,haplotype	ERBB3	NM_001982.4	2	c.132C>T	p.Asn44=	synonymous_variant					38	0.0
	ERBB3(27.4%)	exon3,c.310G>A,p.V104M	0.274	0.001893	1894|724	738|0	0.27603	5374|2049	12	56478854	56478854	G	A	PASS	ERBB3	NM_001982.4	3	c.310G>A	p.Val104Met	missense_variant	Likely_pathogenic		Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Neoplasm_of_uterine_cervix|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Gallbladder_carcinoma|Uterine_carcinosarcoma|Malignant_neoplasm_of_body_of_uterus		37	0.0
	ERBB3(31.9%)	exon6,c.635C>T,p.P212L	0.319	0.037	116|54	35|0	0.33636	146|74	12	56481600	56481600	C	T	PASS	ERBB3	NM_001982.4	6	c.635C>T	p.Pro212Leu	missense_variant				COSV57266207	31	0.0
	MVK(15.9%)	exon5,c.417del,p.A141fs	0.159	0.167	28|5	6|0	0.13889	31|5	12	110019239	110019240	GC	G	PASS	MVK	NM_000431.4	5	c.417del	p.Ala141fs	frameshift_variant	Pathogenic		Hyperimmunoglobulin_D_with_periodic_fever		39	0.0
	PTPN11(30.6%)	exon12,c.1381G>A,p.A461T	0.306	0.007603	700|297	186|0	0.29230	1121|463	12	112926248	112926248	G	A	PASS	PTPN11	NM_002834.5	12	c.1381G>A	p.Ala461Thr	missense_variant&splice_region_variant	Pathogenic		Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_1|RASopathy|LEOPARD_syndrome_1|not_specified|not_provided		39	0.0
-	BRCA2(2.1%)	exon10,c.1813del,p.I605fs	0.021	0.011	1873|55	618|11	0.02734	5159|145	13	32907420	32907421	GA	G	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Fanconi_anemia_complementation_group_D1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided		31	0.0
	BRCA2(26.9%)	exon11,c.3159A>C,p.L1053F	0.269	0.001197	1573|579	1168|1	0.27394	4535|1711	13	32911651	32911651	A	C	PASS	BRCA2	NM_000059.4	11	c.3159A>C	p.Leu1053Phe	missense_variant					33	0.0
-	BRCA2(1.7%)	exon23,c.9097dup,p.T3033fs	0.017	0.008559	1569|34	531|6	0.01997	3680|75	13	32954022	32954022	C	CA	contamination,normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided		42	0.0
	NBEA(1.1%)	exon22,c.3362del,p.N1121fs	0.011	0.005659	2066|30	977|7	0.01058	4861|52	13	35733662	35733663	TA	T	contamination,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362del	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		34	0.0
-	RB1(5.0%)	exon7,c.608-4del	0.05	0.024	3867|261	2660|92	0.05735	23587|1435	13	48934140	48934141	AT	A	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_provided		41	0.0
-	RB1(2.6%)	exon7,c.608-4dup	0.026	0.04	3867|150	2660|145	0.04332	23587|1068	13	48934140	48934141	AT	ATT	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant	Benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome		40	0.0
-	RB1(0.4%)	exon7,c.608-3C>T	0.003874	0.002512	4531|21	3154|11	0.00571	29078|167	13	48934150	48934150	C	T	clustered_events,haplotype,normal_artifact,low_allele_frac	RB1	NM_000321.3	6	c.608-3C>T		splice_region_variant&intron_variant					38	0.0
	DICER1(28.7%)	exon26,c.5552G>A,p.R1851H	0.287	0.011	532|211	118|0	0.28971	787|321	14	95557422	95557422	C	T	PASS	DICER1	NM_177438.3	26	c.5552G>A	p.Arg1851His	missense_variant	Uncertain_significance		Goiter,_multinodular_1,_with_or_without_Sertoli-Leydig_cell_tumors|Hereditary_cancer-predisposing_syndrome|DICER1_syndrome		40	0.0
	MINAR1(30.9%)	exon2,c.2104del,p.S702fs	0.309	0.046	142|63	29|0	0.27941	196|76	15	79750585	79750586	TA	T	distinguished	MINAR1	NM_015206.3	2	c.2104del	p.Ser702fs	frameshift_variant					27	0.0
	BLM(2.4%)	exon7,c.1544del,p.N515fs	0.024	0.013	2814|97	634|10	0.02731	7445|209	15	91304138	91304139	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome		46	0.0
	BLM(1.1%)	exon7,c.1544dup,p.N515fs	0.011	0.02	2814|55	634|14	0.02705	7445|207	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome		41	0.0
	CHD2(7.1%)	exon29,c.3734del,p.K1245fs	0.071	0.039	764|67	157|9	0.06210	1329|88	15	93540315	93540316	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_specified|not_provided		42	0.0
	CHD2(2.5%)	exon29,c.3734dup	0.025	0.025	764|31	157|5	0.03696	1329|51	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Likely_benign(1)	Developmental_and_epileptic_encephalopathy_94		51	0.0
	CHD2(2.7%)	exon33,c.4173del,p.K1391fs	0.027	0.087	277|7	35|2	0.02331	419|10	15	93545433	93545434	GA	G	normal_artifact,slippage,weak_evidence,suspected_bg	CHD2	NM_001271.4	33	c.4173del	p.Lys1391fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Uncertain_significance(1)	Intellectual_disability|not_specified		27	0.0
	IGF1R(42.4%)	exon11,c.2216G>A,p.R739Q	0.424	0.067	57|40	19|0	0.43519	61|47	15	99465391	99465391	G	A	PASS	IGF1R	NM_000875.5	11	c.2216G>A	p.Arg739Gln	missense_variant	protective		Growth_delay_due_to_insulin-like_growth_factor_I_resistance		36	0.0
-	CREBBP(23.9%)	exon16,c.3250del,p.I1084fs	0.239	0.034	359|116	41|0	0.23676	519|161	16	3817720	3817721	CT	C	distinguished	CREBBP	NM_004380.3	16	c.3250del	p.Ile1084fs	frameshift_variant&splice_region_variant					44	0.0
	TVP23A(33.6%)	exon5,c.420del,p.F140fs	0.336	0.027	920|465	178|5	0.32923	1742|855	16	10867202	10867203	TA	T	distinguished	TVP23A	NM_001079512.4	5	c.420del	p.Phe140fs	frameshift_variant					39	0.0
	NQO1(1.8%)	exon6,c.559C>T,p.P187S	0.018	0.001721	2967|57	884|0	0.01070	7950|86	16	69745145	69745145	G	A	contamination,background,chemotherapy_site	NQO1	NM_000903.3	6	c.559C>T	p.Pro187Ser	missense_variant	Pathogenic|_risk_factor		Lung_carcinoma|Benzene_toxicity,_susceptibility_to|Leukemia,_post-chemotherapy,_susceptibility_to|Breast_cancer,_post-chemotherapy_poor_survival_in		47	0.0
	TP53(29.9%)	exon5,c.524G>A,p.R175H	0.299	0.013	855|374	311|2	0.29827	1788|760	17	7578406	7578406	C	T	PASS	TP53	NM_000546.6	5	c.524G>A	p.Arg175His	missense_variant	Pathogenic		Li-Fraumeni_syndrome_1|Hepatocellular_carcinoma|Neoplasm|Breast_neoplasm|Neoplasm_of_ovary|Choroid_plexus_papilloma|Carcinoma_of_colon|Bone_osteosarcoma|Carcinoma_of_pancreas|Colorectal_cancer|Malignant_tumor_of_esophagus|Adrenocortical_carcinoma,_hereditary|Squamous_cell_carcinoma_of_the_head_and_neck|Basal_cell_carcinoma,_susceptibility_to,_7|Hereditary_cancer-predisposing_syndrome|Nasopharyngeal_carcinoma|Familial_cancer_of_breast|Li-Fraumeni_syndrome|Lip_and_oral_cavity_carcinoma|Glioma_susceptibility_1|not_provided		34	0.0
-	NF1(1.1%)	exon2,c.61-4del	0.011	0.039	744|14	124|6	0.01908	1491|29	17	29482988	29482989	CT	C	contamination,multiallelic,normal_artifact,slippage,suspected_bg	NF1	NM_000267.3	1	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Neurofibromatosis,_familial_spinal|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis-Noonan_syndrome|Hereditary_cancer-predisposing_syndrome|Neurofibromatosis,_type_1|not_specified|not_provided		56	0.0
-	NF1(3.2%)	exon2,c.61-4dup	0.032	0.024	744|35	124|3	0.03620	1491|56	17	29482988	29482989	CT	CTT	contamination,multiallelic,normal_artifact,slippage,distinguished	NF1	NM_000267.3	1	c.61-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Neurofibromatosis,_type_1|not_provided		42	0.0
	TOP2A(23.4%)	exon34,c.4303del,p.R1435fs	0.234	0.037	184|55	27|0	0.23138	289|87	17	38546380	38546381	CT	C	distinguished	TOP2A	NM_001067.4	34	c.4303del	p.Arg1435fs	frameshift_variant					36	0.0
	STAT3(30.8%)	exon9,c.832C>T,p.R278C	0.308	0.063	252|117	22|0	0.30310	315|137	17	40486033	40486033	G	A	PASS	STAT3	NM_139276.3	9	c.832C>T	p.Arg278Cys	missense_variant	Uncertain_significance		Hyper-IgE_recurrent_infection_syndrome_1|STAT3_gain_of_function|not_provided		42	0.0
	LMAN1(33.3%)	exon8,c.912del,p.E305fs	0.333	0.00566	2196|1152	864|14	0.34232	7197|3746	18	57013193	57013194	CT	C	clustered_events,multiallelic,distinguished	LMAN1	NM_005570.4	8	c.912del	p.Glu305fs	frameshift_variant					36	0.0
	BAX(1.4%)	exon3,c.121del,p.E41fs	0.014	0.018	472|16	60|0	0.01491	1189|18	19	49458970	49458971	TG	T	multiallelic,slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon		34	0.0
	BAX(30.7%)	exon3,c.121dup,p.E41fs	0.307	0.033	472|211	60|2	0.28200	1189|467	19	49458970	49458971	TG	TGG	multiallelic,slippage,distinguished	BAX	NM_138761.4	3	c.121dup	p.Glu41fs	frameshift_variant	Uncertain_significance		Carcinoma_of_colon|Inborn_genetic_diseases		40	0.0
	TEAD2(32.3%)	exon10,c.895del,p.H299fs	0.323	0.031	426|211	46|0	0.29754	798|338	19	49850472	49850473	TG	T	distinguished	TEAD2	NM_001256660.2	10	c.895del	p.His299fs	frameshift_variant					39	0.0
	NCOA3(3.7%)	exon20,c.3759_3761del,p.Q1254del	0.037	0.041	179|6	23|0	0.02277	472|11	20	46279814	46279817	TGCA	T	clustered_events,contamination,slippage,distinguished	NCOA3	NM_181659.3	20	c.3759_3761del	p.Gln1254del	disruptive_inframe_deletion					22	0.0
	NCOA3(2.9%)	exon20,c.3753G>A,p.Q1251=	0.029	0.037	219|7	31|0	0.02202	533|12	20	46279827	46279827	G	A	clustered_events,contamination,background	NCOA3	NM_181659.3	20	c.3753G>A	p.Gln1251=	synonymous_variant				COSV59065286	42	0.0
	NCOA3(2.6%)	exon20,c.3792A>G,p.Q1264=	0.026	0.022	359|11	58|0	0.05257	865|48	20	46279866	46279866	A	G	clustered_events,contamination,background	NCOA3	NM_181659.3	20	c.3792A>G	p.Gln1264=	synonymous_variant	Likely_benign		not_provided		17	0.0
	GGT1(3.8%)	exon13,c.1283G>A,p.S428N	0.038	0.048	206|8	27|0	0.06291	283|19	22	25023893	25023893	G	A	contamination,multiallelic	GGT1	NM_001288833.2	13	c.1283G>A	p.Ser428Asn	missense_variant				COSV50637964	61	0.0
	GGT1(2.1%)	exon13,c.1283_1284delinsAT,p.S428N	0.021	0.048	206|4	27|0	0.01394	283|4	22	25023893	25023894	GC	AT	contamination,multiallelic	GGT1	NM_001288833.2	13	c.1283_1284delinsAT	p.Ser428Asn	missense_variant					51	0.0
	GGT1(6.8%)	exon13,c.1305A>G,p.V435=	0.068	0.058	162|13	23|0	0.09600	226|24	22	25023915	25023915	A	G	contamination	GGT1	NM_001288833.2	13	c.1305A>G	p.Val435=	synonymous_variant				COSV50638343	38	0.0
-	EP300(23.6%)	exon20,c.3671+1G>A	0.236	0.007265	1106|323	221|0	0.23464	1781|546	22	41556727	41556727	G	A	PASS	EP300	NM_001429.4	20	c.3671+1G>A		splice_donor_variant&intron_variant	Pathogenic		Rubinstein-Taybi_syndrome_due_to_EP300_haploinsufficiency|not_provided		51	0.0
	EP300(22.0%)	exon26,c.4195G>A,p.D1399N	0.22	0.006393	932|255	230|0	0.21633	1507|416	22	41565529	41565529	G	A	PASS	EP300	NM_001429.4	26	c.4195G>A	p.Asp1399Asn	missense_variant	Likely_pathogenic		Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Carcinoma_of_esophagus|Squamous_cell_lung_carcinoma|Neoplasm_of_uterine_cervix|Squamous_cell_carcinoma_of_the_head_and_neck		49	0.0
	CYP2D6(7.0%)	exon7,c.1027C>T,p.R343W	0.07	0.048	269|18	29|0	0.06354	339|23	22	42523595	42523595	G	A	chemotherapy_site	CYP2D6	NM_000106.6	7	c.1027C>T	p.Arg343Trp	missense_variant					21	0.0
	CYP2D6(13.7%)	exon3,c.471C>T,p.A157=	0.137	0.071	51|9	13|0	0.16667	65|13	22	42525069	42525069	G	A	chemotherapy_site	CYP2D6	NM_000106.6	3	c.471C>T	p.Ala157=	synonymous_variant					55	0.0
	BCORL1(59.4%)	exon13,c.5042del,p.P1681fs	0.594	0.033	47|78	29|0	0.62437	74|123	X	129190010	129190011	TC	T	distinguished	BCORL1	NM_021946.5	13	c.5042del	p.Pro1681fs	frameshift_variant					23	0.0
